Form 4: H.B. Fuller Executive VP and CFO, John J. Corkrean, Reports Changes in Beneficial Ownership
SEC Filing Form 4
John J. Corkrean, Executive VP and CFO of H.B. Fuller, filed a Form 4 detailing changes in his beneficial ownership of the company's stock and derivative securities.
Summary
- On October 29, 2024, John J. Corkrean, Executive VP and CFO of H.B. Fuller, filed a Form 4 with the SEC.
- The filing reports changes in his beneficial ownership of H.B. Fuller's securities.
- The reported holdings include common stock, phantom units, employee stock options, and restricted stock units.
- Corkrean directly owns 47,187 shares of common stock.
- He also holds various employee stock options with exercise prices ranging from $43.48 to $77.72 and expiration dates between 2026 and 2034.
- Corkrean possesses restricted stock units that vest in three annual installments.
- The filing indicates the acquisition of 104.86 phantom units on October 25, 2024, which convert into common stock on a 1-for-1 basis.
- The filing also includes restricted stock units acquired through dividend equivalent reinvestment features.
Sentiment
Score: 6
Explanation: The document is a standard SEC filing, indicating routine transactions. The sentiment is neutral, reflecting the transparency of insider holdings.
Positives
- The reporting person's continued holding of a significant number of shares and options indicates confidence in the company's future.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. They are closely watched by investors seeking insights into management's perspective on the company's stock.
Stakeholder Impact
- Shareholders can use this information to understand the alignment of management's interests with their own.
Key Dates
| Date | Description |
|---|---|
| 05/17/2017 | Date of grant for employee stock options exercisable until 05/17/2026 at $43.48. |
| 01/26/2018 | Date of grant for employee stock options exercisable until 01/26/2027 at $50.1. |
| 01/25/2019 | Date of grant for employee stock options exercisable until 01/25/2028 at $53.57. |
| 01/24/2020 | Date of grant for employee stock options exercisable until 01/24/2029 at $45.05. |
| 01/24/2021 | Date of grant for employee stock options exercisable until 01/24/2030 at $48.35. |
| 01/27/2022 | Date of grant for employee stock options exercisable until 01/27/2031 at $51.89. |
| 01/24/2023 | Date of grant for employee stock options exercisable until 01/24/2032 at $72.94 and restricted stock units vesting until 01/24/2025. |
| 01/24/2024 | Date of grant for employee stock options exercisable until 01/24/2033 at $68.17 and restricted stock units vesting until 01/24/2026. |
| 01/26/2025 | Date of grant for employee stock options exercisable until 01/26/2034 at $77.72 and restricted stock units vesting until 01/26/2027. |
| 10/25/2024 | Date of transaction involving phantom units. |
| 10/29/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.